- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00419627
Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
January 5, 2007 updated by: Hillel Yaffe Medical Center
Proteomic Analysis of Serology and Peptides Presented on the HLA Complex of Breast, Ovarian, Colon, Rectal, Gastric and Pancreatic Adenocarcinoma.
The purpose of this study is to evaluate the presence of proteins in solid tumors which may lead to an immune response
Study Overview
Status
Unknown
Detailed Description
The main objective of the study is to evaluate which proteins are presented by the HLA complex of solid tumors.
Secondary objectives include to evaluate whether an immune response specific to these proteins has actually been provoked and whether there is a similar immune response following recurrence.
Real specimens will be evaluated using PCR and mass spectrometry.
Study Type
Observational
Enrollment
160
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Itamar Ashkenazi, M.D.
- Phone Number: 972-4-6304761
- Email: i_ashkenazi@yahoo.com
Study Locations
-
-
-
Hadera, Israel, 38100
- Hillel Yaffe Medical Center
-
Contact:
- Itamar Ashkenazi, M.D.
- Phone Number: 972-4-6304761
- Email: i_ashkenazi@yahoo.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with adenocarcinoma of breast, colon, rectum, ovary , stomach, pancreas
Exclusion Criteria:
- Withdrawal of consent
- Small specimen which does not allow to retrieve tissue without interfering with pathologic evaluation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Natural History
- Time Perspectives: Prospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Itamar Ashkenazi, M.D., Hillel Yaffe Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2007
Study Registration Dates
First Submitted
January 5, 2007
First Submitted That Met QC Criteria
January 5, 2007
First Posted (Estimate)
January 8, 2007
Study Record Updates
Last Update Posted (Estimate)
January 8, 2007
Last Update Submitted That Met QC Criteria
January 5, 2007
Last Verified
January 1, 2007
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Skin Diseases
- Neoplasms by Site
- Endocrine System Diseases
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Gastrointestinal Diseases
- Stomach Diseases
- Endocrine Gland Neoplasms
- Breast Diseases
- Colonic Diseases
- Intestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Pancreatic Diseases
- Neoplasms
- Stomach Neoplasms
- Breast Neoplasms
- Colorectal Neoplasms
- Pancreatic Neoplasms
Other Study ID Numbers
- ProtHYMC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stomach Neoplasms
-
Jeeyun LeeRecruitingStomach Cancer, AdenocarcinomaKorea, Republic of
-
Chinese University of Hong KongUnknown
-
Chinese University of Hong KongUnknown
-
National Cancer Center, KoreaUnknownSubmucosal Tumor of StomachKorea, Republic of
-
Chinese University of Hong KongRecruiting
-
Universitätsklinikum Hamburg-EppendorfOvesco Endoscopy AGSuspendedSubmucosal Tumor of StomachGermany
-
Xijing Hospital of Digestive DiseasesCompletedStomach Cancer | Esophageal Cancer | Esophageal Dysplasia | Stomach DysplasiaChina
-
Soonchunhyang University HospitalCompletedMalignant Neoplasm of Stomach | Benign Neoplasm of StomachKorea, Republic of
-
Federation Francophone de Cancerologie DigestiveEli Lilly and CompanyActive, not recruitingStomach Cancer | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma | Stomach NeoplasmFrance
-
MedImmune LLCCompletedHER2 Expressing Breast or Gastric/Stomach CancersUnited States